Accurate Wealth Management LLC Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Accurate Wealth Management LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,686 shares of the healthcare conglomerate’s stock after selling 90 shares during the quarter. Accurate Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,920,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. M&T Bank Corp raised its position in UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC lifted its holdings in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after buying an additional 1,193 shares during the period. Benjamin Edwards Inc. grew its stake in UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after buying an additional 41,308 shares during the last quarter. Parsifal Capital Management LP acquired a new stake in UnitedHealth Group in the third quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC increased its stake in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.5 %

Shares of UNH opened at $543.76 on Wednesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a 50 day moving average price of $554.45 and a 200 day moving average price of $563.12. The stock has a market capitalization of $500.41 billion, a price-to-earnings ratio of 35.42, a PEG ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.56 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.